Citi upgrades ZymoGenetics (Nasdaq: ZGEN) from Sell to Hold. Price target $9.

Citi analyst says, "While we view ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE